Cannabis Law Report

AUGUST 10, 2021

The UK is a significant country for us for many reasons, and we are proud to be able to offer a medicine, that has been developed and is manufactured here, to even more patients across the UK. GW’s development programme represents the only well-controlled clinical evaluation of a cannabinoid medication for patients with refractory epilepsy.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

MMJ Recs

FEBRUARY 18, 2024

As society re-evaluates its stance on cannabis, a growing body of research is uncovering the therapeutic potential of this plant. Research has identified cannabinoids such as THC (tetrahydrocannabinol) and CBD (cannabidiol) as key players in the plant’s therapeutic effects.

Chronic Pain 52

Chronic Pain Marijuana Epilepsy Research and Development 52

MMJ Recs

DECEMBER 17, 2023

Enacted in 2015, the program was designed to provide a narrow avenue for patients suffering from qualifying conditions to access low-THC cannabis under the supervision of qualified healthcare professionals. Current Texas Medical Marijuana Regulations CBD laws in Texas are governed by the Compassionate Use Program.

Law 52

Law Dispensary Clinical Trials Programs 52

MMJ Recs

MARCH 28, 2024

From researching qualified doctors to scheduling appointments and discussing treatment options, we provide practical insights and tips to help patients confidently navigate this journey. Patients should research and familiarize themselves with these professionals to ensure they receive appropriate guidance and care.

Patients 52

Patients Treatment Research and Development Therapy 52

MMJ Recs

MARCH 14, 2024

Qualifying Conditions for Medical Marijuana in West Virginia West Virginia’s medical marijuana program encompasses an extensive list of qualifying conditions, providing access to patients with various chronic or debilitating diseases.

Dispensary 52

Dispensary Programs Legalization Marijuana 52

The Cannigma

MARCH 14, 2023

Cancer, HIV, epilepsy and other serious conditions were the first accepted uses of cannabis in the United States. Laws restricting birth control, abortion, drug use, as well as requirements to receive welfare, drug treatment and even pain medication are developed in a paternalistic nature.

Policy 96

Policy Research and Development Conditions Consumption 96

Puff Puff Post

JANUARY 1, 2020

As cannabis legalisation spreads, research has found considerable use in for cannabis in medicine. One particularly promising area of research is in the treatment of cancer. As a result, medical usage now grows substantially now that doctors and hospitals have access to legal cannabis. Portugal subsidises medical cannabis.

Treatment 64

Treatment Clinical Trials Research and Development Cannabinoids 64

SpeedWeed

AUGUST 9, 2021

Argentinian health authorities are now providing access to cannabis derivatives for medicinal, therapeutic and palliative purposes. The first supply of medical cannabis for pediatric patients with epilepsy at the Buenos Aires National Children’s Garrahan Hospital was finally delivered. Shutterstock. It modified Law No.

Epilepsy 52

Epilepsy Research and Development Medicine Patients 52

MMJ Recs

FEBRUARY 27, 2024

Dispensaries serve as the primary access point for patients seeking medical marijuana products. Currently, Florida has a limited number of dispensaries strategically located across the state to ensure accessibility for patients with qualifying conditions. Medications, physical therapy, and, in some cases, surgery may be recommended.

Dispensary 93

Dispensary Legalization Marijuana Therapy 93

Greencamp

AUGUST 16, 2018

In this comprehensive guide, we are exploring the research on using cannabis for treating Amyotrophic lateral sclerosis (ALS)—a rare neuron disease that targets the motor neurons in the body. Exploring the available research on ALS and cannabinoids. Marijuana and Epilepsy: Here’s How Cannabis Stops Seizures (12 Studies).

Strains 94

Strains Cannabinoids Research and Development Indica 94

MMJ Recs

FEBRUARY 3, 2024

Pennsylvania Medical Cannabis Program and Philadelphia Marijuana Dispensaries The Pennsylvania Medical Cannabis Program serves as the foundation for medical marijuana accessibility in Philadelphia. Navigating these changes can create uncertainty in the industry and affect patient access.

Legislation 52

Legislation Law Marijuana Dispensary 52

Puff Puff Post

JANUARY 1, 2020

As cannabis legalisation spreads, research has found considerable use in for cannabis in medicine. One particularly promising area of research is in the treatment of cancer. As a result, medical usage now grows substantially now that doctors and hospitals have access to legal cannabis. Portugal subsidises medical cannabis.

Treatment 40

Treatment Clinical Trials Research and Development Cannabinoids 40

Veriheal

SEPTEMBER 27, 2021

The United Kingdom’s Multiple Sclerosis (MS) Society has taken a stand against restricted access to medical cannabis in the country. Medical cannabis has been legal in the nation for almost three years—so why are MS patients struggling to access the treatment? Yet many people with MS are still unable to access it.”

Treatment 98

Treatment Patients Access Research and Development 98

Cannabis Law Report

DECEMBER 18, 2019

Notably, the increase comes after the company recently broke into the European pharma-market after getting green-lighted from the Irish Government to sell its phytocannabinoid-derived “CannEpil” product to epilepsy sufferers. Both products are proprietary medicinal drugs developed internally through MGC’s research and development divisions.

Research and Development 59

Research and Development Clinical Trials Seed-To-Sale Pharmaceutical 59

Cannabis Law Report

JANUARY 27, 2022

Accessible via Australia’s Therapeutic Goods Administration (TGA) Special Access Scheme and Authorized Prescriber Scheme (where individual applications are approved), whole flower options including 1:1 (THC 10 CBD 10), mid-range (17), and high THC (25) varieties of 15g bag GMP-Certified medical cannabis will be made available.

Education 52

Education Research and Development Medicine Epilepsy 52

Veriheal

MAY 17, 2023

Despite access restrictions, the government has taken a more relaxed stance towards the usage of medicinal cannabis across the country, which is known for being one of the world’s busiest ports. As of 2021, just two Singaporeans with treatment-resistant epilepsy have been approved to use medicinal cannabis in the form of Epidiolex.

Research and Development 83

Research and Development Medicine Treatment Epilepsy 83

The Cannigma

JUNE 15, 2021

Both THC and CBD were first isolated in a laboratory in the early 1940s by American researcher Roger Adams. It wasn’t until the 1960s, however, that Israeli researcher Raphael Mechoulam properly identified the chemical structure of CBD, which led to the wealth of knowledge and scope of research we have today. Shutterstock).

CBD 122

CBD Research and Development Epilepsy Extraction 122

Cannabis Law Report

JULY 25, 2022

Medical marijuana is legal in Pennsylvania but it can be accessed only by registered patients with a medical marijuana card. Although a lot of research is being conducted on the subject, no conclusive medical data has been provided to the medical community. Can I Buy Medical Marijuana in Pennsylvania? Anxiety disorders. HIV / AIDS.

Legalization 52

Legalization Marijuana Epilepsy Sativa 52

Cannabis Law Report

MARCH 2, 2020

The UK government has eased import restrictions on medicinal cannabis, but has admitted it needs to do much more to improve access for patients. In November last year, the National Institute for Health and Care Excellence (NICE) recommended 2 cannabis-based medicinal products for patients with multiple sclerosis and hard-to-treat epilepsies.

Medicine 59

Medicine Research and Development Clinical Trials Patients 59

Veriheal

AUGUST 31, 2020

We are humbled to introduce you to them and their exceptional ideas, ranging from community grassroots mental health efforts designed to empower historically vulnerable communities of color, to research plans for identifying strain specific genetics. Veriheal’s Innovation in Cannabis Scholarship 2020 Winners . Nishtha Tripathi.

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

JULY 6, 2021

Currently, therapies for common neurological disorders such as concussion, migraine and cluster headache, neuropathic pain syndromes, and chronic epilepsy have limitations, especially when these disorders are associated with chronic psychological challenges.

Therapy 66

Therapy Research and Development Treatment Patients 66

Cannabis Law Report

SEPTEMBER 24, 2019

T he EU has approved for the first time the use of a medicinal cannabis product aimed at patients with two rare, but severe, forms of childhood epilepsy. The medication, developed by GW Pharmaceuticals, will be used in combination with another epilepsy medication called clobazam. What about other medical cannabis products?

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

Cannabis Law Report

JANUARY 27, 2022

New York’s legislation includes a psilocybin services grant program that provides financial assistance to veterans and first responders who want to access psilocybin services. However, one possible pro of New York’s medical approach is the focus on research. Washington: the “Adult Use” Approach. Shared Traits of Each Approach.

Legalization 52

Legalization Research and Development Legislation Treatment 52

WeedAdvisor

SEPTEMBER 26, 2019

Created for the treatment of two severe childhood epilepsy disorders – Lennox Gastaut Syndrome (LGS) and Dravet Syndrome – the drug recently received approval for use in the European Union. Many companies are developing cannabis-based therapies and focusing on cultivation and distribution of cannabis.”. The Talk of the Town”. .

CBD 40

CBD Pharmaceutical Research and Development Epilepsy 40

Veriheal

FEBRUARY 24, 2023

An NYU study found that CBD could help those with epilepsy, Washington’s mushroom legalization bill hit a major roadblock, and Maryland is looking to include social equity in its forthcoming recreational market. This new CBD-epilepsy study comes from NYU’s Grossman School of Medicine.

Epilepsy 99

Epilepsy CBD Legalization Research and Development 99

MMJ Recs

DECEMBER 22, 2023

Historically, marijuana was vilified and classified as a Schedule I controlled substance, which hindered both research and public acceptance. One of the key drivers of this shift is the increasing body of scientific research highlighting the medical properties of cannabinoids, the active compounds in marijuana.

Marijuana 52

Marijuana Chronic Pain Advocacy Research and Development 52

MedicalJane

JUNE 29, 2018

The FDA announced in a press release on Monday that it had approved the “first drug comprised of an active ingredient derived from marijuana to treat rare, severe forms of epilepsy.”. On June 26, 2018, the FDA granted approval of Epidiolex, a cannabidiol (CBD) oral solution, to GW Research Ltd (GW). Prior to this week, the U.S.

Clinical Trials 53

Clinical Trials CBD DEA Research and Development 53

Veriheal

MAY 31, 2022

opioid epidemic, which claimed a record number of lives in 2021 , is the result of America’s faulty regulation of these powerful pain-killing drugs and a widespread lack of access to safe and adequate pain management solutions. Rapidly growing research and personal reports suggest medical cannabis could be the answer.

Programs 52

Programs Chronic Pain Treatment Conditions 52

Cannabis Law Report

DECEMBER 9, 2019

Although research on CBD is still in its infancy, to date there have been dozens of studies with more on the horizon. Why so little research? Up until December of 2015, regulatory limitations put in place by the FDA prohibited researchers from conducting CBD-related trials in the US. Anxiety and Inflammation Lead the Pack.

Pets 59

Pets CBD Research and Development Epilepsy 59

WeedAdvisor

MARCH 29, 2019

While CBD was already well-known to many medical users, those with only recreational access quickly fell into the hype. The most extensive research involved patients with severe – often untreatable – epilepsy. WeedAdvisor’s Continued Coverage of Industry Developments. . Claims About CBD Drive Demand. .

Oil 40

Oil CBD Research and Development Epilepsy 40

United Patients Group

APRIL 24, 2023

In addition, cannabis might also help improve heart health by reducing inflammation around vessels; this reduces the risk of developing atherosclerosis (the hardening of arteries) or plaque buildup inside them. In addition to these potential side effects, some epilepsy medications have been linked with depression and suicidal thoughts.

Blood Pressure 52

Blood Pressure Sleep Cannabinoids Research and Development 52

The Joint Blog

JUNE 4, 2021

Those state laws allow medical marijuana to be used to treat ailments like Alzheimer’s, cancer, epilepsy, Crohn’s disease, seizures, hepatitis C and a host of others. The United States Food and Drug Administration (FDA) has only cannabis use to treat two rare and severe forms of epilepsy: Dravet syndrome and Lennox-Gastaut syndrome.

Conditions 32

Conditions Chronic Pain Marijuana Research and Development 32

Cannabis Law Report

MAY 14, 2019

In anticipation of an imminent opioid crisis, last year the UK government announced that medical cannabis would be accessible by prescriptions through the NHS—from clinicians and for those with exceptional clinical needs—as of November 2018. There is little or no domestic research, and they don’t like trusting overseas research.

Research and Development 45

Research and Development Chronic Pain Epilepsy Medicine 45

WeedAdvisor

APRIL 8, 2019

With this kind of accessibility, CBD’s popularity skyrocketed in all 50 states. Research is being done into several claims about CBD, specifically anxiety, depression and pain relief. That being said, we will continue to monitor advancements in CBD research and happily report new findings as they develop. The post U.S.

Food 40

Food CBD Research and Development Treatment 40

Cannabis Law Report

MAY 7, 2019

Shareholders and investors need to be aware that adverse enforcement actions could affect their investments and that Liht’s ability to access private and public capital could be affected and or could not be available to support continuing operations. Veritas Pharma Inc. CTL“), is advancing the science behind medical cannabis.

Compliance 63

Compliance Compliance Research and Development Strains 63

Cannabis Law Report

JUNE 14, 2019

I’m proud to establish the medical marijuana advisory committee to help expand patient access, and to advance and modernize policies to move Florida into the future of medical marijuana,” Fried said. It’s a medicine that an overwhelming majority of Floridians came together for, calling for constitutionally guaranteed access.”.

Agriculture 40

Agriculture Marijuana Research and Development Policy 40

Cannabis Law Report

JUNE 1, 2021

Steve Barbera to Vice President, Market Access. Drake is well-known as an inspiring and inclusive leader who is dedicated to the development of her teams and solely focused on organizational success for the benefit of patients. Julie Hoff to Vice President, Human Resources. Prior to joining Sesen Bio, Dr. McLin was Sr.

Research and Development 66

Research and Development Treatment Pharmaceutical Patients 66